A phase I study of ATR inhibitor BAY1895344 (elimusertib) plus topotecan (ETCTN 10402): Results of dose escalation.
| Publication | Article in Journal of Clinical Oncology, published May 2024 |
|---|---|
| Authors | Shannon Stockton, Cathy Shyr, Michael Cecchini, Raid Aljumaily, Thorvardur Ragnar Halfdanarson,...[ show more ] |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…